---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295270030.md"
description: "Compass Therapeutics shares are trading higher after Piper Sandler raised its price target on the stock from $4 to $6."
datetime: "2026-08-07T18:28:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295270030.md)
  - [en](https://longbridge.com/en/news/295270030.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295270030.md)
generator: "portal-rs"
---

# 

Compass Therapeutics shares are trading higher after Piper Sandler raised its price target on the stock from $4 to $6.

### Related Stocks

- [CMPX.US](https://longbridge.com/en/quote/CMPX.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)

## Related News & Research

- [Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 | CMPX Stock News](https://longbridge.com/en/news/293052670.md)
- [Compass Showcases Promising Tovecimig Data, Eyes Commercialization](https://longbridge.com/en/news/291469511.md)
- [Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win](https://longbridge.com/en/news/289061027.md)
- [Analyst Maintains Buy on Tovecimig Developer, Sees PFS Strength Underappreciated and Keeps $24 Price Target Unchanged](https://longbridge.com/en/news/284246322.md)
- [Compass Therapeutics To Present Phase 1 Data Results Of CTX-8371 At ASCO 2026](https://longbridge.com/en/news/287599766.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**